Blue Cloud Softech Solutions launched BluHealth Platform v2.0, an AI-driven, enterprise-grade health tech solution. Featuring non-invasive diagnostics, remote monitoring, and HIPAA/GDPR compliance, it aims to improve healthcare access, especially in underserved regions, with global expansion plans and strong market potential.
Blue Cloud Softech Solutions Limited (BCSSL), a prominent global provider of Cybersecurity and technology solutions, announced today the launch of its BluHealth Platform v2.0. This new version transforms the platform from a proof-of-concept to an AI-integrated, enterprise-grade solution designed for large-scale healthcare delivery. The launch signifies a significant expansion of the company's presence in the global digital health industry.
The BluHealth Platform v2.0 introduces several advanced features, including AI-powered clinical decision support, instant medical interpretations, and intelligent care routing. It also incorporates non-invasive HbA1c testing and 60-second facial scan screenings, facilitated by the BluHealth Scanner, along with rugged, field-ready hardware enabled by the BluHealth Screener.
The platform is fully interoperable, HIPAA/GDPR compliant, and ready for universal health coverage initiatives, aiming to redefine digital health for underserved communities globally.
Recognised for its potential in population health management, the BluHealth Platform is expected to drive cost-effective and accessible diagnostics, generating significant global interest, particularly in the Middle Eastern and African markets.
The global digital health industry is projected to grow substantially, with a market size of $288.55 billion in 2024, expected to reach $946.04 billion by 2030, demonstrating a Compound Annual Growth Rate (CAGR) of 22.22%, according to GRAND VIEW RESEARCH.
Blue Cloud Softech Solutions estimates a potential business pipeline of up to $6 million with existing customers for this product version.
The state-of-the-art solution integrates advanced technologies, including non-invasive HbA1c testing and a multi-sensor platform capable of measuring ECG, EMG, PPG, and GSR. Its AI-powered clinical decision support adheres to global standards with FHIR/HL7 integration.
include an AI Screening Ecosystem with advanced AI integration for instant preliminary medical interpretations, an AI-First Design to reduce clinician workload and enhance diagnostic accuracy, and basic AI screening implementation for intelligent care routing and real-time recommendations to healthcare providers.
The platform offers Remote Vital Signs Monitoring through Remote Photoplethysmography (rPPG) for non-invasive vital sign measurement, including heart rate and HbA1c without blood samples. The 60-second facial scanning technology provides comprehensive health analytics quickly, and a multi-sensor platform incorporates ECG, EMG, GSR, and temperature sensors for expanded monitoring. Offline functionality ensures real-time health assessments even in remote or disaster-stricken areas.
The hardware prototype development focuses on field-ready, rugged devices built for extreme environmental conditions, portable multi-sensor hardware with clinical-grade accuracy, full-stack hardware-software integration to minimise fragmentation and improve reliability, and proven institutional deployability across PHCs, hospitals, and diagnostic labs.
For population health management, the platform offers dashboard functionality to visualize health data for large-scale population trends, high-volume screening support for chronic disease management and mobile health campaigns, enterprise-grade integration with plug-and-play compatibility with healthcare systems (FHIR/HL7 support) , and alignment with universal health coverage initiatives, tailored for underserved and rural healthcare scenarios.
The compliance and security architecture ensures HIPAA and GDPR compliance, robust security infrastructure for safe data handling, and a regulatory-ready design to streamline approval for institutional and national-scale healthcare programs. Rapid diagnostic capabilities include AI-powered triage for automated early-stage diagnostics and patient flow direction, emergency response readiness for fast-paced medical scenarios, and cost-efficient diagnostics for democratized access to quality care.
On Friday, Blue Cloud Softech Solutions share price hit a 2% upper circuit to ₹34.77 per share.
Blue Cloud Softech Solutions Limited is a global technology company and solution provider. Their expertise lies in delivering customised surveillance systems that integrate advanced AI, IoT, and cloud technologies. They focus on enhancing security and enabling proactive threat management for various sectors, as evidenced by their recent coastal surveillance project win. The company is listed on the Bombay Stock Exchange (BSE).
Disclaimer: The article is for informational purposes only and not investment advice.
For android only